Research Management Group (RMG)

Pfizer Center for Therapeutic Innovation (CTI)
Request for Translational Proposals: Biotherapeutic Targets

**Funding opportunity for Stanford faculty with PI eligibility and CE faculty (with an approved PI waiver obtained prior to the pre-proposal submission). This is an opportunity for Stanford faculty to submit pre-proposals that will be evaluated by Pfizer CTI for a potential collaboration. Stanford PIs may subsequently be invited to full proposals (and will work with their RPM/RMG or OSR at that time).

# of applicants: unlimited numbers of pre-proposals are permitted.

Timeline:
Internal pre-proposal deadline:  Friday, April 21, 2017, 5 p.m. (see pre-proposal submission guidelines below)
Full proposals by invitation only.



Eligibility:

 

Amount of funding: not specified.
The term can range from 1 to 5 years.
Per the pre-negotiated terms on the agreement Stanford University has with Pfizer CTI, CTI will provide full IDC reimbursement.

 

Guidelines: This RFP is not on the sponsor's website.
Download a PDF file of the program announcement and pre-proposal guidelines >> PDF file
Download a Word document containing the pre-proposal template >>  word



Questions? Contact Persons:
Faculty interested in investigating a potential collaboration with CTI are encouraged to contact Dr. Mary Faris (Mary.Faris@pfizer.com) to discuss their ideas and suitability for a CTI pre-proposal. Mary will also be available to address questions regarding pre-proposal content, proposal guideline, scientific review or Pfizer’s disease areas of interest, etc.

For questions about the pre-proposal submission process, please contact Jeanne Heschele, Research Management Group, at jheschele@stanford.edu.


Purpose:

CTI: an innovative Pfizer program https://www.pfizercti.com/ that partners with leading academic medical centers and foundations nationwide to accelerate the translation of novel targets to the clinic. CTI seeks to identify and partner novel targets with the goal of identifying new compounds and accelerate drug development from validated target to proof-of-mechanism in humans.

A partnership with CTI may include collaborative use of Pfizer’s technologies, publishing rights, and financial awards in the form of milestone and royalty payments for successful programs, in addition to providing appropriate funds for carrying out the collaborative work.

(*Note: Stanford University has an agreement in place with CTI.)


Modalities (required):

 

Therapeutic Areas of Interest-Spring 2017

 

What they look for:

 

Out of scope:
As a general rule, CTI is currently unable to accept therapeutics that are radiotherapy, nanoparticles, RNAi or vaccines in nature. In addition, there is limited opportunity to pursue HIV targeted therapies within CTI.


INTERNAL PRE-PROPOSAL SUBMISSION GUIDELINES:


By Friday, April 21, 2017, 5 p.m., please submit one PDF file containing the following in the order listed below via email attachment to:

Please read-message from OTL: Your pre-proposal should not contain any confidential information, as Pfizer will not treat the pre-proposal as confidential. Disclosure of confidential intellectual property in a pre-proposal may jeopardize your ability to protect such intellectual property.

Jeanne Heschele
Research Management Group
jheschele@stanford.edu
650-245-2351

File name: Last name_Pfizer_CTI_2017.pdf

Institutional representatives: you do not have to submit your pre-proposals through your RPM/RMG or your OSR contract/grant officer for their approval. You can submit your pre-proposal directly to Jeanne. If subsequently invited to submit a full proposal, then you would work with your RPM/RMG or OSR. Exception: CE faculty must submit a CE faculty PI waiver through their RPM 1-2 weeks prior to the April 21st deadline (see below**)

1) Pre-proposal (2-3 pages)
Download the Pre-Proposal template word document
Include the completed pre-proposal in the PDF file to be sent to Jeanne Heschele.
(Reminder-only projects with Large Molecules: antibodies, proteins, peptides, ADCs, fusion proteins, are eligible.)


2) NIH Biosketch for PI and Co-PI(s)

3) CE faculty only**: please send a separate PDF file to Jeanne Heschele at jheschele@stanford.edu containing your approved CE faculty PI waiver request by the April 21st deadline as well.Reminder: CE faculty you must submit your CE faculty PI waiver request >> through your Research Process Manager (RPM in RMG >>) at least 1-2 weeks prior to the pre-proposal deadline




Selection process
Jeanne Heschele will submit all of the Stanford PI's pre-proposals online to Pfizer CTI. The recommendation on which pre-proposals advance to the full proposal round will be made by Pfizer CTI. Invitations will then be sent to those PI ‘s to submit full proposals. PIs will work with their RPMs/RMG or OSR when submitting a full proposal. Funding decisions on full proposals will be evaluated by CTI.



 

Footer Links: